Contribution of CsrR-Regulated Virulence Factors to the Progress and Outcome of Murine Skin Infections by Streptococcus pyogenes

Infection and Immunity

Volumn 72, Issue 2, 2004, Pages 623-628

  Engleberg, N Cary ^a,b   Heath, Andrew ^a   Vardaman, Kristal ^a   DiRita, Victor J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXOTOXIN; GENE PRODUCT; HYALURONIC ACID; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; COLONY FORMING UNIT; CONTROLLED STUDY; CSRR GENE; CSRRS GENE; GENE; GENE CONTROL; GENE LOCUS; GENE MUTATION; LETHALITY; MOUSE; NONHUMAN; NUDE MOUSE; NULL CELL; OUTCOMES RESEARCH; PRIORITY JOURNAL; SKIN INFECTION; STRAIN DIFFERENCE; STREPTOCOCCUS PYOGENES;

ANIMALS; BACTERIAL PROTEINS; CYSTEINE ENDOPEPTIDASES; HYALURONIC ACID; MALE; MICE; MICE, INBRED HRS; REPRESSOR PROTEINS; SKIN DISEASES, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; STREPTOLYSINS; VIRULENCE FACTORS;

EID: 0842327156     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.2.623-628.2004     Document Type: Article

References (36)

1. Alouf, J. E., and C. Loridan. 1988. Production, purification, and assay of streptolysin S. Methods Enzymol. 165:59-64.
2. Ashbaugh, C. D., H. B. Warren, V. J. Carey, and M. R. Wessels. 1998. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J. Clin. Investig. 102:550-560.
3. Ashbaugh, C. D., and M. R. Wessels. 2001. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect. Immun. 69:6683-6688.
4. Betschel, S. D., S. M. Borgia, N. L. Barg, D. E. Low, and J. C. De Azavedo. 1998. Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect. Immun. 66:1671-1679.
5. Burns, E. H., Jr., A. M. Marceil, and J. M. Musser. 1996. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect. Immun. 64:4744-4750.
6. Cywes, C., I. Stamenkovic, and M. R. Wessels. 2000. CD44 as a receptor for colonization of the pharynx by group A streptococcus. J. Clin. Investig. 106:995-1002.
7. Cywes, C., and M. R. Wessels. 2001. Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature 414:648-652.
8. Engleberg, N. C., A. Heath, A. Miller, C. Rivera, and V. J. DiRita. 2001. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J. Infect. Dis. 183:1043-1054.
9. Federle, M., K. McIver, and J. Scott. 1999. A response regulator that represses transcription of several virulence operons in the group A streptococcus. J. Bacteriol. 181:3649-3657.
10. Ginsburg, I., P. Ward, and J. Varani. 1999. Can we learn from the pathogenetic strategies of group A hemolytic streptococci how tissues are injured and organs fail in post-infectious and inflammatory sequelae? FEMS Immunol. Med. Microbiol. 25:325-338.
11. Graham, M. R., L. M. Smoot, C. A. Lux Migliaccio, K. Virtaneva, D. E. Sturdevant, S. F. Porcella, M. J. Federle, G. J. Adams, J. R. Scott, and J. M. Musser. 2002. Virulence control in group A streptococci by a two-compenent gene regulatory system: global expression profiling and in vivo infection modeling. Proc. Natl. Acad. Sci. USA 99:13855-13860.
12. Heath, A., V. J. DiRita, N. L. Barg, and N. C. Engleberg. 1999. A two-component regulatory system, CsrR/CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect. Immun. 67:5298-5305.
13. Heath, A., A. Miller, V. J. DiRita, and C. N. Engleberg. 2001. Identification of a major, CsrRS-regulated secreted protein of group A streptococcus. Microb. Pathog. 31:81-89.
14. Herwald, H., M. Collin, W. Muller-Esterl, and L. Bjorck. 1996. Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J. Exp. Med. 184:665-673.
15. Higuchi, R. 1990. Recombinant PCR, p. 177-183. In M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, Inc., San Diego, Calif.
16. Hoe, N. P., J. Vuopio-Varkila, M. Vaara, D. Grigsby, D. De Lorenzo, Y. X. Fu, S. J. Dou, X. Pan, K. Nakashima, and J. M. Musser. 2001. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype MI group A streptococcus infection. J. Infect. Dis. 183:633-639.
17. Humar, D., V. Datta, D. J. Bast, B. Beall, J. C. De Azavedo, and V. Nizet. 2002. Streptolysin S and necrotising infections produced by group G streptococcus. Lancet 359:124-129.
18. Hytonen, J., S. Haataja, D. Gerlach, A. Podbielski, and J. Finne. 2001. The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin-binding and cysteine protease activity. Mol. Microbiol. 39:512-519.
19. Kansal, R. G., M. A., D. E. Low, A. Norrby-Teglund, and M. Kotb. 2000. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect. Immun. 68:6362-6369.
20. Kapur, V., S. Topouzis, M. W. Majesky, L. L. Li, M. R. Hamrick, R. J. Hamill, J. M. Patti, and J. M. Musser. 1993. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb. Pathog. 15:327-346.
21. Kuo, C. F., J. J. Wu, K. Y. Lin, P. J. Tsai, S. C. Lee, Y. T. Jin, H. Y. Lei, and Y. S. Lin. 1998. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect. Immun. 66:3931-3935.
22. Lei, B., S. Mackie, S. Lukomski, and J. M. Musser. 2000. Identification and immunogenicity of group A streptococcus culture supernatant proteins. Infect. Immun. 68:6807-6818.
23. Levin, J. C., and M. R. Wessels. 1998. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A streptococcus. Mol. Microbiol. 30:209-219.
24. Lukomski, S., S. Sreevatsan, C. Amberg, W. Reichardt, M. Woischnik, A. Podbielski, and J. M. Musser. 1997. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Investig. 99:2574-2580.
25. Morrissey, P. J., D. R. Parkinson, R. S. Schwartz, and S. D. Waksal. 1980. Immunologic abnormalities in HRS/J. mice. I. Specific deficit in T lymphocyte helper function in a mutant mouse. J. Immunol. 125:1558-1562.
26. Moses, A. E., M. R. Wessels, K. Zalcman, S. Alberti, S. Natanson-Yaron, T. Menes, and E. Hanski. 1997. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A streptococcus. Infect. Immun. 65:64-71.
27. Musser, J., S. Kanjilal, U. Shah, D. Musher, N. Barg, K. Nelson, R. K. Selander, K. Johnson, P. Schlievert, J. Henrichsen, D. Gerlach, R. Rakita, A. Tanna, B. Cookson, and J. Huang. 1993. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J. Infect. Dis. 167:337-346.
28. Nizet, V., B. Beall, D. J. Bast, V. Datta, L. Kilburn, D. E. Low, and J. C. De Azavedo. 2000. Genetic locus for streptolysin S production by group A streptococcus. Infect. Immun. 68:4245-4254.
29. Perez-Casal, J., J. A. Price, E. Maguin, and J. R. Scott. 1993. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol. Microbiol. 8:809-819.
30. Ravins, M., J. Jaffe, E. Hanski, I. Shetzigovski, S. Natanson-Yaron, and A. E. Moses. 2000. Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies. J. Infect. Dis. 182:1702-1711.
31. Reske-Kunz, A. B., M. P. Scheid, and E. A. Boyse. 1979. Disproportion in T-cell subpopulations in immunodeficient mutant hr/hr mice. J. Exp. Med. 149:228-233.
32. Saouda, M., W. Wu, P. Conran, and M. D. Boyle. 2001. Streptococcal pyrogenic exotoxin B enhances tissue damage initiated by other Streptococcus pyogenes products. J. Infect. Dis. 184:723-731.
33. Scaramuzzino, D. A., J. M. McNiff, and D. E. Bessen. 2000. Humanized in vivo model for streptococcal impetigo. Infect. Immun. 68:2880-2887.
34. Svensson, M. D., D. A. Scaramuzzino, U. Sjobring, A. Olsen, C. Frank, and D. E. Bessen. 2000. Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol. Microbiol. 38: 242-253.
35. Watanabe, Y., Y. Todome, H. Ohkuni, S. Sakurada, T. Ishikawa, T. Yutsudo, V. A. Fischetti, and J. B. Zabriskie. 2002. Cysteine protease activity and histamine release from the human mast cell line HMC-1 stimulated by recombinant streptococcal pyrogenic exotoxin B/streptococcal cysteine protease. Infect. Immun. 70:3944-3947.
36. Wolf, B. B., C. A. Gibson, V. Kapur, M. Hussaini, J. M. Musser, and S. L. Gonias. 1994. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J. Biol. Chem. 269:30682-30687.